Franklin, Parlapiano, Turner & Welch’s AbbVie ABBV Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$541K	Hold	2,151	–	–	0.12%	44
2026 Q1	$432K	Hold	2,151	–	–	0.1%	44
2025 Q4	$461K	Hold	2,151	–	–	0.11%	42
2025 Q3	$498K	Hold	2,151	–	–	0.13%	40
2025 Q2	$399K	Hold	2,151	–	–	0.1%	42
2025 Q1	$451K	Hold	2,151	–	–	0.12%	41
2024 Q4	$382K	Hold	2,151	–	–	0.1%	43
2024 Q3	$425K	Hold	2,151	–	–	0.11%	41
2024 Q2	$369K	Hold	2,151	–	–	0.1%	43
2024 Q1	$392K	Hold	2,151	–	–	0.11%	41
2023 Q4	$333K	Sell	2,151 -40	-2%	-$5.83K	0.1%	43
2023 Q3	$327K	Hold	2,191	–	–	0.1%	43
2023 Q2	$295K	Buy	2,191 +200	+10%	+$29.3K	0.09%	43
2023 Q1	$317K	Hold	1,991	–	–	0.1%	42
2022 Q4	$322K	Hold	1,991	–	–	0.11%	41
2022 Q3	$267K	Hold	1,991	–	–	0.1%	42
2022 Q2	$305K	Sell	1,991 -98	-5%	-$15K	0.1%	41
2022 Q1	$339K	Hold	2,089	–	–	0.1%	42
2021 Q4	$283K	Buy	2,089 +98	+5%	+$11.6K	0.08%	45
2021 Q3	$215K	Hold	1,991	–	–	0.07%	49
2021 Q2	$224K	Hold	1,991	–	–	0.07%	48
2021 Q1	$215K	Hold	1,991	–	–	0.07%	48
2020 Q4	$213K	Buy	+1,991	New	+$191K	0.08%	45
2017 Q2	–	Sell	-1,663	Closed	-$108K	–	47
2017 Q1	$108K	Hold	1,663	–	–	0.05%	56
2016 Q4	$104K	Hold	1,663	–	–	0.05%	60
2016 Q3	$105K	Hold	1,663	–	–	0.05%	59
2016 Q2	$103K	Buy	1,663 +1,400	+532%	+$85.3K	0.05%	53
2016 Q1	$15K	Hold	263	–	–	0.01%	93
2015 Q4	$16K	Buy	+263	New	+$15.1K	0.01%	95

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's ABBV Position: Q2 2026 in Review

Franklin, Parlapiano, Turner & Welch held its AbbVie (ABBV) position steady in Q2 2026 at 2,151 shares worth $541K. The position accounts for 0.12% of the portfolio, ranked #44.

Franklin, Parlapiano, Turner & Welch first reported a position in ABBV in Q4 2015 and has held it in 29 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Franklin, Parlapiano, Turner & Welch held 2,151 shares of AbbVie worth $541K as of Q2 2026.
Franklin, Parlapiano, Turner & Welch left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.12% of Franklin, Parlapiano, Turner & Welch's portfolio in Q2 2026, its #44 holding.
Franklin, Parlapiano, Turner & Welch first reported a position in AbbVie in Q4 2015 and has held it in 29 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2026, filed 9 Jul 2026.